Skip to content
healthcare.dev

neostigmine methylsulfate

NDC 31722-995, neostigmine methylsulfate, injection, from Camber Pharmaceuticals Inc..

Product NDC
31722-995
Status
Listed
Labeler
Camber Pharmaceuticals Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212512
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-995 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
31722-995-313172209953110 VIAL, MULTI-DOSE in 1 CARTON (31722-995-31) / 10 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d07ff23f-54a5-4036-8005-a3515d4e2194

Use it

Look up 31722-995 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-995 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-995. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.